Retrospective Data Analysis With the Aim to Determine the Success Rate of Endotracheal Intubation in the First Attempt in the Zug Rescue Service With Various Airway Devices Already in Everyday Use (AWARE)
Retrospektive Analyse Von Patientendaten bezüglich Die notfallmässige Atemwegssicherungen Durch Den Rettungsdienst Zug (Airway Management Analysis in the Rescue Environment of the Emergency Service Zug) - Retrospective Analysis of Patient Data Regarding the Emergency Airway Management by the Rescue Service Zug
Study Overview
Status
Status
Conditions
Conditions
Intervention / Treatment
Intervention / Treatment
Detailed Description
Study Type
Study Type
Enrollment (Estimated)
Enrollment
Contacts and Locations
Study Contact
Study Contact
- Name: Benedikt Florian Scherr, MD
- Phone Number: +41754385339
- Email: benedikt.scherr@zg.ch
Study Contact Backup
- Name: Felix Brinkmann, MSc
- Email: felix.brinkmann@zg.ch
Study Locations
-
-
-
Zug, Switzerland, 6300
- Rettungsdienst Zug
-
-
Participation Criteria
Eligibility Criteria
Eligibility Criteria
Ages Eligible for Study
- Adult
- Older Adult
Accepts Healthy Volunteers
Sampling Method
Study Population
Description
Inclusion Criteria:
- All adult patients who have had their airway secured by endotracheal intubation by RDZ staff
Exclusion Criteria:
- Existence of a documented refusal.
- Age < 18 years.
Study Plan
How is the study designed?
Design Details
Number of groups / cohorts
Cohorts and Interventions
Group / CohortGroup / Cohort |
Intervention / TreatmentIntervention / Treatment |
|---|---|
|
videolaryngocopy with bougie (S Guide)
|
bougie (S Guide)
videolaryngoscopy hyperangulated or Macintosh
|
|
conventional laryngoscopy with bougie (S Guide)
|
bougie (S Guide)
|
|
videolaryngoscopy with introducer
|
videolaryngoscopy hyperangulated or Macintosh
|
|
conventional laryngoscopy with introducer
|
What is the study measuring?
Primary Outcome Measures
Primary Outcome Measures
Outcome Measure |
Time Frame |
|---|---|
|
Success rate (first pass success) with Video laryngoscope with Macintosh blade "C-MAC" used in the Zug rescue service
Time Frame: January 2020 to January 2025
|
January 2020 to January 2025
|
|
Success rate (first pass success) with the hyperangulated video laryngoscope "D-BLADE" in the Zug rescue service
Time Frame: January 2020 to January 2025
|
January 2020 to January 2025
|
|
Success rate (first pass success) with Conventional laryngoscope in the Zug rescue service
Time Frame: January 2020 to January 2025
|
January 2020 to January 2025
|
|
Success rate (first pass success) with Surgical airway protection in the Zug rescue service
Time Frame: January 2020 to January 2025
|
January 2020 to January 2025
|
|
Success rate (first pass success) with the Bougie/tube introducer in the Zug rescue service
Time Frame: January 2020 to January 2025
|
January 2020 to January 2025
|
|
Success rate (first pass success) with the Stylet/guide rod in the Zug rescue service
Time Frame: January 2020 to January 2025
|
January 2020 to January 2025
|
Secondary Outcome Measures
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Incidence of airways retrospectively assessed as definitively difficult
Time Frame: January 2020 to January 2025
|
proportion of "definitive difficult airway" to "anticipated difficult airway" and "unanticipated difficult airway"
|
January 2020 to January 2025
|
|
Incidence of mechanical damage
Time Frame: January 2020 to January 2025
|
January 2020 to January 2025
|
|
|
Portion of Medical/non-medical occupational patients
Time Frame: January 2020 to January 2025
|
January 2020 to January 2025
|
|
|
Incidence of drop in saturation SpO2 <90%
Time Frame: January 2020 to January 2025
|
January 2020 to January 2025
|
|
|
Correlation of succes rate and years of clinical experience of the intubator
Time Frame: January 2020 to January 2025
|
January 2020 to January 2025
|
|
|
Proportion of day or night shift on intubations with first pass effect
Time Frame: January 2020 to January 2025
|
January 2020 to January 2025
|
|
|
Patient demographics (median age, proportion of gender)
Time Frame: January 2020 to January 2025
|
January 2020 to January 2025
|
|
|
Reason for initiating resuscitation/DAI
Time Frame: January 2020 to January 2025
|
January 2020 to January 2025
|
Collaborators and Investigators
Sponsor
Sponsor
Investigators
Investigators
- Principal Investigator: Benedikt Florian Scherr, MD, Rettungsdienst Zug
Study record dates
Study Major Dates
Study Start (Actual)
Study Start
Primary Completion (Estimated)
Primary Completion
Study Completion (Estimated)
Study Completion
Study Registration Dates
First Submitted
First Submitted
First Submitted That Met QC Criteria
First Submitted That Met QC Criteria
First Posted (Actual)
First Posted
Study Record Updates
Last Update Posted (Actual)
Last Update Posted
Last Update Submitted That Met QC Criteria
Last Update Submitted That Met QC Criteria
Last Verified
Last Verified
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
Other Study ID Numbers
- AWARE
- 2024-02051 (Other Identifier: Ethics Committee Northwestern and Central Switzerland EKNZ)
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
product manufactured in and exported from the U.S.
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.